Results 101 to 110 of about 8,165 (189)

Cardiovascular safety of febuxostat versus allopurinol among the Asian patients with or without gout: A systematic review and meta‐analysis

Clinical and Translational Science
The cardiovascular (CV) safety of febuxostat compared to allopurinol for the treatment of hyperuricemia among Asian patients is uncertain. In this study, we conducted a systematic review and meta‐analysis to compare the CV safety profiles of febuxostat ...
Jian‐hao Deng, Peng‐hui Lai, Li‐shan Xie, Shu‐sheng Qiu, De‐sheng Qiu, Jia‐xing Zhang   +5 more
doaj   +1 more source

Bioequivalance and pharmacokinetic study of febuxostat in human plasma by using LC-MS/MS with liquid liquid extraction method [PDF]

, 2013

core   +1 more source

Comparative assessment of the effects of dotinurad and febuxostat on the renal function in chronic kidney disease patients with hyperuricemia

Scientific Reports
Although hyperuricemia is associated with chronic kidney disease (CKD), the impact of uric acid (UA)-lowering drugs on CKD has been controversial.
Tomoaki Takata, Sosuke Taniguchi, Yukari Mae, Kana Kageyama, Yudai Fujino, Takuji Iyama, Katsuya Hikita, Takaaki Sugihara, Hajime Isomoto   +8 more
doaj   +1 more source

Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations [PDF]

, 2017
Hiroshi Miyata, Hiroshi Suzuki, Hirotaka Matsuo, Kimiyoshi Ichida, Tappei Takada, Yu Toyoda   +5 more
core   +1 more source

The British Society For Rheumatology guideline for the management of gout [PDF]

, 2017
Cameron, Stewart, Carr, Alison, Davenport, Graham, Doherty, Michael, Forrester, Harry, Hui, Michelle, Jenkins, Wendy, Jordan, Kelsey M., MacDonald, Thomas, Mallen, Christian D., Nuki, George, Pywell, Anthony, Roddy, Edward, Zhang, Weiya   +13 more
core   +2 more sources

Xanthine oxidase inhibitory and antioxidant potential of Indian Muscodor species [PDF]

, 2016
Neha Kapoor, Sanjai Saxena
core   +1 more source

Predictors of reaching a serum uric acid goal in patients with gout and treated with febuxostat

ClinicoEconomics and Outcomes Research, 2017
Richard Sheer,1 Kyle D Null,2 Keith A Szymanski,2 Lavanya Sudharshan,1 Jennifer Banovic,2 Margaret K Pasquale1 1Comprehensive Health Insights, Inc., Louisville, KY, 2Takeda Pharmaceuticals U.S.A., Inc., Deerfield, IL, USA Purpose: Clinical guidelines ...
Sheer R, Null KD, Szymanski KA, Sudharshan L, Banovic J, Pasquale MK   +5 more
doaj  

Febuxostat [PDF]

, 2020
openaire   +1 more source

Febuxostat in the management of hyperuricemia and chronic gout: a review

Therapeutics and Clinical Risk Management, 2008
Miao Hu, Brian TomlinsonDivision of Clinical Pharmacology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, ChinaAbstract: Febuxostat is a novel, potent, non ...
Miao Hu, Brian Tomlinson
doaj  

Treatment sequence patterns of urate-lowering therapy in Korean patients with gout: A common data model-based study. [PDF]

PLoS One
Kim MJ, Park EG, Kim C, Kang DY, Ryu B, Shin K.   +5 more
europepmc   +1 more source